Soluble CD4: the first step

Editorial

E C Tramont et al. Ann Intern Med. 1990.

. 1990 Feb 15;112(4):241-2.

doi: 10.7326/0003-4819-112-4-241.

No abstract available

Comment on

Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial.
Schooley RT, Merigan TC, Gaut P, Hirsch MS, Holodniy M, Flynn T, Liu S, Byington RE, Henochowicz S, Gubish E, et al. Schooley RT, et al. Ann Intern Med. 1990 Feb 15;112(4):247-53. doi: 10.7326/0003-4819-112-4-247. Ann Intern Med. 1990. PMID: 2297203
The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.
Kahn JO, Allan JD, Hodges TL, Kaplan LD, Arri CJ, Fitch HF, Izu AE, Mordenti J, Sherwin JE, Groopman JE, et al. Kahn JO, et al. Ann Intern Med. 1990 Feb 15;112(4):254-61. doi: 10.7326/0003-4819-112-4-. Ann Intern Med. 1990. PMID: 2297204